Agios Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) Transcript
Great. Thank you, everyone, for joining us today. So my name is Mohit Bansal, I'm one of the biotech analysts here at Citi. And I'm very happy to have today team Agios. So we have Jackie Fouse, the CEO of the company. We also have Kendra Adams, she's the VP, IR; and we also have Holly Manning, the Director of IR with the company. Thank you, Jackie, Kendra and Holly for joining us today.
Thanks for having us, Mohit. Happy to be here.
Questions & Answers
Great. So maybe just to start with, why don't we start with you giving us a brief overview of Agios. It has been -- I think it was 2018 biotech conference that morning because announced that you are you're joining Agios as a CEO, you did not join right there, but it has been a little less than 2 years now. So last year, you have had success with the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
